60 filings
8-K
REVB
Revelation Biosciences Inc
16 May 24
Submission of Matters to a Vote of Security Holders
4:03pm
8-K
REVB
Revelation Biosciences Inc
10 May 24
Results of Operations and Financial Condition
4:57pm
8-K
REVB
Revelation Biosciences Inc
22 Mar 24
Results of Operations and Financial Condition
4:22pm
8-K
REVB
Revelation Biosciences Inc
11 Mar 24
Regulation FD Disclosure
9:53pm
8-K
REVB
Revelation Biosciences Inc
8 Feb 24
Revelation Biosciences Inc. Announces Pricing of $6.2 Million Public Offering
4:01pm
8-K
0qnr dgmqjtsv0
30 Jan 24
Developing innovative therapeutics to address unmet needs Corporate Presentation / January 2024 www.revbiosciences.com
5:21pm
8-K
m1vjbu7czg8uvdrqc680
23 Jan 24
Material Modifications to Rights of Security Holders
4:18pm
8-K
4skiy6t9h152zn8qztf
22 Jan 24
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
9fk8dzp3
13 Nov 23
Results of Operations and Financial Condition
4:30pm
8-K
m4crr
12 Oct 23
Developing innovative therapeutics to address unmet needs Corporate Presentation / October 2023 www.revbiosciences.com
4:26pm
8-K
85nenw kz9s
2 Oct 23
Revelation Biosciences Inc. Announces Appointment of Lakhmir Chawla, M.D. to Board of Directors
4:24pm
8-K
i15jiliki wh
11 Aug 23
Results of Operations and Financial Condition
4:30pm
8-K
4bb9ry
11 Aug 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
qgyeambbrr5m6lnpv
14 Jul 23
Submission of Matters to a Vote of Security Holders
4:51pm
8-K
tlmue s9y
7 Jul 23
Amendments to Articles of Incorporation or Bylaws
4:07pm
8-K
tpqrlb5i l6jt
29 Jun 23
Regulation FD Disclosure
4:23pm
8-K
u2xwn7qb 2qnuqpt
12 Jun 23
Regulation FD Disclosure
4:20pm
8-K
8x1ovz
25 May 23
Developing innovative therapeutics to address unmet needs Corporate Presentation / May 2023 www.revbiosciences.com
4:32pm
8-K
tn900lt4z7sa9 httxrz
22 May 23
Results of Operations and Financial Condition
1:22pm
8-K
40e19mkxci2fn
3 Apr 23
Results of Operations and Financial Condition
4:33pm